The lumen of the gut contains a complex consortium of microbes. The gut microbiome, that these microbes collectively constitute, profoundly influences nutritional, physiologic and protective processes in the human host. Their activity includes the fermentation of unabsorbed dietary carbohydrate with production of short chain fatty acids, production of vitamins like biotin and vitamin K, mediation of immune responses and oral tolerance, and protection of the host against invasion by pathogenic microbes[@ref1]. In healthy individuals, there is a balance between beneficial and pathogenic constituents of the microbiota. Alterations in this balance can lead to a state of dysbiosis that contributes to illness and morbidity[@ref2][@ref3]. Metchnikoff was the first to associate lactic acid bacteria (LAB) in fermented yogurt with health and longevity of certain Balkan communities[@ref4]. The concept of probiotic microbes that he introduced has led to the widespread consumption of food preparations containing LAB and/or bifidobacteria, with the expectation that they will confer health benefits including reduction of cholesterol levels, improvement of immune function, resistance to infectious diseases, and prevention of colon cancer[@ref5]. The Food and Agricultural Organization (FAO) defines probiotics as live microorganisms, which when administered in adequate amounts, confer a health benefit on the host and suggests that a number of *in vitro* characteristics may be used to predict whether a specific microbe will have probiotic properties, before subjecting them to more rigorous tests to prove that they provide a health benefit[@ref6]. These are echoed in regional and societal guidelines[@ref7][@ref8].

Fermented foods containing LAB are traditionally used every day as food in many cultures. Curd, prepared by fermentation of milk with an inoculum of previously made curd, is used in most households in southern India where it constitutes a significant part of the daily diet. The LAB that ferment the milk are likely to differ slightly in each household as there is no standardized starter culture used to prepare curd. Although curd is believed to have probiotic properties[@ref9][@ref10], there is little documentation of this in the literature. This study was, therefore, undertaken to evaluate the LAB from home-made curd in southern India for probiotic properties.

Material & Methods {#sec1-1}
==================

*Bacterial strains and source*: Clinical isolates of a pathogenic *Escherichia coli*, *Vibrio cholerae* O139, *Salmonella* Typhimurium strain and *Shigella flexneri* were kindly donated by the Department of Clinical Microbiology, Christian Medical College and Hospital (CMCH), Vellore, Tamil Nadu, India.

*Growth medium*: *Vibrio* was grown in alkaline peptone water while the remaining pathogenic strains were grown in brain heart infusion broth (Hi-media, Mumbai, India) at 37°C. Total viable counts of the LAB isolates were determined using de Man Rogosa Sharpe (MRS) agar at 37°C. *Shigella* and *Salmonella* were enumerated on Salmonella Shigella (SS) agar (Hi-media, Mumbai, India), *E. coli* on MacConkey agar (Hi-media, Mumbai, India) and *V. cholerae* on thiosulphate-citrate-bile salts-sucrose (TCBS) agar (Hi-media, Mumbai, India) after 18 h at 37°C.

*Isolation of LAB and their identification by API 50CH*: The study was carried out in the department of Gastrointestinal Sciences, CMCH, Vellore, Tamil Nadu, India between 2008 and 2010. Samples of freshly made curd were obtained from 16 households within a 50 km radius of Vellore and transported immediately to the laboratory. The households chosen belonged to laboratory researchers who made curd each day at home using a small portion of curd to inoculate milk which was then left covered overnight at room temperature. Curd samples were transported to the laboratory in the morning and were plated on MRS agar and incubated overnight at 37^°^C. Microbial colonies that grew out in culture were identified by Gram stain, catalase test and biochemical characterization[@ref11]. API 50 CH was used in conjunction with API 50 CHL (bioMerieux, Chennai, India) medium for the identification of LAB. Strains identified by the API 50CH system were subjected to growth curve analysis to determine the time period during which exponential growth was seen. LAB were cultured on Lactobacillus MRS broth (Himedia, Mumbai, India) for 16 h at 37°C with 10 per cent CO~2~ under anaerobic conditions and used for testing.

*Growth kinetics of LAB*: The profile of LAB growth during curd formation was explored through time course studies involving laboratory fermentation of milk using curd as starter culture. Inocula of fresh curd were used to seed three (two pasteurized, one unpasteurized) 150 ml aliquots of milk at 1 per cent (w/v) concentration. The milk was allowed to ferment for 48 h at room temperature and a 1.5 ml aliquot removed every 4 h for culture and for deoxyribonucleic acid (DNA) isolation. The samples were streaked on MRS agar, MacConkey agar and blood agar plates. MRS agar plates were incubated for 24 h at 37°C in anaerobic conditions with 10 per cent CO~2~, while MacConkey agar and blood agar plates were incubated for 48 h at 37°C. After incubation, colonies were enumerated and variations in colony morphology at different durations were noted. DNA was isolated from the curd samples[@ref12] and subjected to real time polymerase chain reaction (PCR) using primers targeted at 16S rRNA gene sequences specific to *Lactobacillus* genus[@ref13][@ref14]. Amplification of lactobacillus sequences was expressed relative to the amplification of sequences conserved for domain bacteria (universal).

*Studies done with LAB*: The following experiments were carried out when the strains were in early stationary phase. The isolates were screened for attributes consistent with probiotic properties. These included resistance to acid and pepsin, bile salt and pancreatin tolerance, antimicrobial resistance, intrinsic antimicrobial production, adhesion to (and inhibition of pathogen adhesion to) Caco-2 intestinal epithelial cells, modulation of IL-8 response in HT-29 colonic epithelial cells and modulation of cytokine expression in THP-1 monocyte cells.

*Tolerance to acid, pepsin, bile and pancreatin and intrinsic haemolytic activity*: The ability of the organisms to survive adverse conditions was assessed by incubating the organisms in MRS broth culture in presence of these adverse influences, and removing aliquots at specified times for plating on MRS agar plates to ascertain growth. The ability of the isolates to survive in the presence of hydrochloric acid (*p*H 1.0 and *p*H 3.0), pepsin (3 mg/ml, *p*H 2.0), pancreatin (1 mg/ml, *p*H 8.0) and bile salts (0.3% w/v Ox Gall) was measured. The reagents for these tests were obtained from Sigma Chemical Co., USA. Intrinsic haemolytic activity was determined by culture on Columbia blood agar plates for 48 h and observing haemolysis around the colonies.

*Antimicrobial susceptibility and activity*: Antimicrobial sensitivity to ampicillin, co-amoxyclav, gentamicin, chloramphenicol, rifampicin, norfloxacin, vancomycin and imipenem were determined using the Kirby-Bauer disc diffusion method[@ref15] (Himedia, Mumbai, India) with standard definitions for antimicrobial resistance or sensitivity[@ref16]. The discs contained the following amounts per disc (in µg): Ampicillin (10), co-amoxyclav (30), gentamicin (10). chloramphenicol (30), rifampicin (5), norfloxacin (10), vancomycin (30), imipenem (10), tetracycline (30).

Intrinsic antimicrobial activity against *E. coli*, *S. Typhimurium*, *V. cholerae* and *S. flexneri* was determined by well-diffusion in BHI soft agar plates and zones of inhibition were measured.

*Adherence to Caco-2 cells*: The ability of the bacteria to adhere to Caco-2 cells[@ref17], a colon cancer cell line with small intestinal differentiation was tested. Caco-2 cells were grown in Dulbecco\'s modified Eagle medium (DMEM) (Sigma Chemical Co., USA), supplemented (v/v) with 10 per cent foetal calf serum inactivated at 56°C for 30 min, 1 per cent non-essential amino acids, 1 per cent glutamine and 20 µg/ml of streptomycin and penicillin, at 37°C in 10 per cent CO~2~/90 per cent air. The cells were seeded into 24-well tissue culture plates (BD, Gurgaon, India) at a concentration of 1 million cells per ml, and incubated for seven days with change of medium every two days. Two ml volumes of early stationary growth phase broth cultures were pelleted, washed and suspended in non-supplemented DMEM to a concentration corresponding to McFarland standard 3. One ml of suspension containing 10^8^ bacteria was overlaid onto the Caco-2 monolayers, and plates incubated at 37°C in 10 per cent CO~2~/90 per cent air for 90 min. The microbial suspension was aspirated, the monolayers washed twice, and 1 ml of 0.1 per cent Triton X-100 added for ten minutes to detach adherent microbial cells. The cells were plated on MRS agar at 1:100 and 1:10000 dilutions and incubated at 37°C in 10 per cent CO~2~/90 per cent air for 24 h, and colonies enumerated[@ref18]. *E. coli* was used as a positive control and the adhesion of the test strains was expressed relative to the *E. coli* adhesion value.

*Inhibition of pathogen adhesion*: The ability of the strains to inhibit pathogen adhesion to Caco-2 cells was also tested *in vitro*[@ref19]. Briefly, Caco-2 monolayers in 24 well plates were overlaid with the test strains for 90 min, after which the bacteria were removed and the cell monolayer washed thrice with DMEM. One ml of DMEM containing 10^8^ *V. cholerae* or *S.* Typhimurium cells was overlaid on the monolayers, incubated for 90 min, and adherent V. cholera or *S.* Typhimurium enumerated using the procedure described above.

*Relative expression of interleukin (IL)-8, IL-10, IL-12, and tumour necrosis factor (TNF)-α by real time PCR and ELISA*: The bacteria were tested for modulation of cytokine expression or release from immune cells. Modulation of interleukin-8 release from HT-29 cells in response to *V. cholerae* was used as a test system to determine putative probiotic properties in the isolated lactic acid bacteria[@ref20]. Pre-exposure to the test isolates (10^8^/ml) for 90 min was followed by exposure of the cell monolayers to 10^8^ *V. cholerae* cells for four h, after which supernatant and cells were separately saved for analysis. IL-8 concentrations in the supernatant were estimated by ELISA (Opt EIA Set, BD Biosciences, USA). Modulation of the cytokine response in THP-1 monocyte-macrophage cell lines was used to investigate the LAB for potential probiotic properties. THP-1 is a human mononuclear leukaemia cell line that can secrete the anti-inflammatory cytokine IL-10 and was grown in flasks, dissociated, washed and resuspended in medium prior to the experiments. THP-1 cell suspension (1×10^6^ cells/ml/well) was placed in 24-well tissue culture plates (Falcon Milliwell, BD, USA), and incubated for one hour. Bacterial cells suspended in non-supplemented RPM1 (10^8^ cells/ml) were added and incubated at 37°C in 10 per cent CO~2~/90 per cent air for two h. The microbial suspension was aspirated from the wells, one ml of fresh RPMI medium containing 20 µg gentamicin added to each well, and incubated at 37°C in 10 per cent CO~2~/90 per cent air for 4 h. The wells were aspirated and the suspensions were centrifuged at 7500 × *g* for 10 min at 4°C. To the pellets, 300 µl of TRI reagent was added and stored at -80°C for RNA isolation. RNA was isolated in batches using TRI reagent and converted to cDNA using a reverse transcriptase core kit (Eurogentec, Liege, Belgium). Expression of the housekeeping gene actin was monitored to confirm cDNA conversion. Real-time PCR using SYBR green[@ref20] was carried out to quantitate IL-10, IL-12 and TNF-α gene expression relative to expression of β-actin, using appropriate primers ([Table I](#T1){ref-type="table"}).

###### 

Primers used in real time PCR
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Results {#sec1-2}
=======

*Growth kinetics of LAB*: [Fig. 1](#F1){ref-type="fig"} shows the proportion of *Lactobacillus* 16S rRNA genes as a proportion of the total 16S rRNA pool in curd and indicates that *Lactobacillus* formed the major microbial population at 12 h. The isolated strains were cultured and aliquots removed at different time points and suspended in phosphate buffer saline (PBS) and compared against McFarland standards. This indicated that microbial concentration in the cultures plateaued at around 16 h ([Fig. 2](#F2){ref-type="fig"}). This was the point of time when the microbes were harvested for studies.

![Growth of lactic acid bacteria (LAB) during milk fermentation to curd at room temperature. The values shown are mean ± SEMof three fermentations. Lactobacilli were quantitated relative to total bacteria by real time polymerase chain reaction targeting 16S rRNA gene sequences specific for lactobacilli.](IJMR-140-345-g002){#F1}

![Growth curve of the LAB in culture. Optical density at 600 nm was used to assess density of growth. Values shown are ± SEMof 14 observations.](IJMR-140-345-g003){#F2}

*Isolation and identification of LAB*: LAB were characterized for biochemical reactions using the *Lactobacillus* API 50CH (bioMerieux India, Chennai) test panel. Following 48 h of incubation, changes in medium colour in each of the 50 cupules were noted, and the strains were then identified using the apiweb™ software (bioMerieux SA, France). Growth curve analysis revealed that *L. fermentum* 1, *Leuconostoc lactis*, *L. acidophilus* 1, *L. confusus* and *L. delbrueckii* ssp. bulgaricus strains showed exponential growth between 4 and 10 h, and the others (*L. acidophilus* 3, *L. delbrueckii* ssp. *delbrueckii*, *L. lindneri*, *Leuconostoc mesenteroides* ssp. *cremoris* and *L. helveticus*) between 6 and 24 h. Thirty five Gram positive bacterial strains were isolated from the curd specimens, 15 of which were clearly identified as distinct species using the API 50CH. These 15 LAB (12 lactobacilli, 1 *Lactococcus* and 2 *Leuconostoc*) and one yeast, each from a separate sample of curd, were taken up for study ([Table II](#T2){ref-type="table"}).

###### 

List of microbial (lactic acid bacteria) species taken up for characterization
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*Ability to survive adverse culture conditions*: On exposure to *p*H 3.0, seven of the survived for one hour and two for 3 h. The per cent of input bacteria that survived ranged from 0 to 6 per cent at the end of 3 h in *p*H 3.0, indicating that the microbiota isolated from curd were not capable of survival in low *p*H. On exposure to *p*H 1.0, none of the strains survived for an hour. None of the strains, except for one of *Lactobacillus delbrueckii* ssp. *delbrueckii*, survived exposure to pepsin at *p*H 2.0. All the strains survived four h of exposure to pancreatin at *p*H 8.0. Similarly, all strains survived exposure to bile salts for 3 h. In the case of pancreatin and bile salts, the survival after 3 h of the individual strains ranged from 77 to 120 per cent of the input bacteria for the different strains.

*Haemolytic capacity and antimicrobial susceptibility in vitro*: None of the strains tested exhibited any sign of haemolysis when grown on blood agar for 24 h under anaerobic conditions. The strains were also tested for evidence of resistance to commonly used antimicrobial classes using antimicrobial disk diffusion and growth for 24 h. All the tested strains were resistant to most of the antimicrobials tested including vancomycin, norfloxacin, ampicillin, chloramphenicol, gentamicin, rifampicin, tetracycline and amoxicillin-clavulanic acid ([Table III](#T3){ref-type="table"}). All strains were sensitive to imipenem.

###### 

Antimicrobial susceptibility pattern of the LAB isolated from curd samples.
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*Intrinsic antimicrobial activity against pathogens*: The intrinsic antimicrobial activity of the isolated strains was tested against four different pathogens using the well diffusion method. Fourteen of the 16 strains tested inhibited the growth of *S.* Typhimurium ([Fig. 3](#F3){ref-type="fig"}). Five strains showed an inhibitory effect towards *V. cholerae* 0139. One strain was able to inhibit *E. coli* and another strain inhibited *Shigella*.

![Intrinsic antimicrobial activity of the LAB strains against several gastrointestinal pathogens. Zones of inhibition (cm) are shown.](IJMR-140-345-g006){#F3}

*Microbial adherence to epithelial cells and inhibition of pathogen adherence*: All the tested strains except *Lactobacillus delbrueckii* ssp. *lactis* were capable of adhering to Caco-2 cells ([Fig. 4](#F4){ref-type="fig"}). Seven of the strains exhibited good adherence ranging from 20-104 per cent when compared to the control *E. coli* used to test epithelial cell adherence which showed adherence of approximately 10^5^ bacteria per well. Adherence intensity of the remaining strains varied from 2-20 per cent compared to the control *E. coli*. Most of the strains were able to inhibit the adherence of *V. cholerae* O139 to Caco-2 cells ([Fig. 5](#F5){ref-type="fig"}). *Vibrio* adherence was inhibited almost completely by two strains - *L. acidophilus* 1 and *L. delbrueckii* ssp. *delbrueckii* - and by 80 per cent by two other strains. The remaining strains showed varying degrees of inhibition of *Vibrio* adherence, ranging from 20 to 60 per cent. Most of the strains did not inhibit adherence of *S.* Typhimurium ([Fig. 5](#F5){ref-type="fig"}).

![Adherence of LAB to Caco-2 cells. The Y-axis shows mean ± SE per cent of input bacteria adhering to the epithelial cell monolayer (n=3 experiments).](IJMR-140-345-g007){#F4}

![Inhibition of *V. cholera*e and *S.* Typhimurium adherence to Caco-2 cells by LABisolated in this study. Values shown are mean±SE colony forming units of pathogen adhering to Caco-2 cells after addition of test microbial strains which are named on the X-axis. Experiments were done in duplicate.](IJMR-140-345-g008){#F5}

*Effects on cytokine secretion by cell lines*: HT-29 cells were exposed to the test strains prior to exposure to *V. cholerae* O139 that is known to induce a brisk IL-8 secretion from these cells. Most of the LAB strains could reduce the IL-8 response to *V. cholerae* by 50-80 per cent ([Fig. 6](#F6){ref-type="fig"}). Two strains each induced increased expression of IL-10 and IL-12 mRNA in THP-1 cells, while the others had no perceptible effect. Most strains induced some expression of TNF-α mRNA in THP-1 cells ([Fig. 7](#F7){ref-type="fig"}).

![Interleukin (IL)-8 secretion in μg/ml (mean+SE) from HT-29 cells in response to exposure to *V. cholerae* and the effect of LAB.](IJMR-140-345-g009){#F6}

![Messenger RNA expression of cytokines in THP-1 cells exposed to the various lactic acid bacilli (LAB). The values are shown as mean±SE (n=3) expression relative to that of beta-actin.](IJMR-140-345-g010){#F7}

Discussion {#sec1-3}
==========

Curd (fermented milk), freshly made by inoculation with starter curd, is a good source of bioavailable vitamin, minerals and folate[@ref21], and has less lactose and galactose than milk. Consumption of curd may enhance the immune response in the elderly. These health benefits have been linked to the presence of live bacteria[@ref22]. It is not hitherto known whether LAB present in home-made curd have the potential to confer health benefits.

The Joint FAO/WHO Working Party Report in 2002[@ref6] suggested that microbes should have a minimum set of characteristics that could predict probiotic potential. These included the ability to resist passage through the stomach in the presence of acid and pepsin, and the ability to grow in the proximal small intestine in the presence of pancreatin and bile salts. Highly potent probiotic strains would have additional properties including antibiotic resistance, adhesion to intestinal epithelia, antimicrobial activity, inhibition of pathogen adhesion, and immunomodulation potential. The FAO/WHO Working Party recommended testing for these properties using reliable *in vitro* screening methods, followed by clinical studies to confirm putative health benefits.

Only one of the strains studied survived exposure to pepsin although several survived exposure to acid for varying periods of time. However, it is unlikely that bacteria ingested in curd will be stressed to the extent as done in the present study, because the food with which curd is eaten is likely to buffer gastric acid and to limit pepsin effect. The *p*H in human stomach ranges from 1.0 during fasting to 4.5 after a meal, and most of the examined strains were resistant to *p*H 3.0 even after 3 h of exposure. These results are consistent with reports of ability of lactobacilli to retain their viability when exposed to *p*H values of 2.5-4.0[@ref23][@ref24]. None of the lactobacilli survived in pepsin at *p*H 2.0, in consonance with published literature[@ref25]. Probiotic bacteria in curd will have the advantage of the presence of curd proteins which have a protective effect on the starters and support bacterial survival in the acidic environment of the stomach[@ref23][@ref25]. Even strains not able to survive at *p*H 1.0 *in vitro* may exhibit substantial viability when consumed as starters or adjuncts in a matrix of fermented milk. In contrast to pepsin, all the strains examined in this study survived in the presence of pancreatin or bile salts simulating the near neutral small intestine environment.

All LAB tested fulfilled the safety requirement that a probiotic strain should not have β-haemolytic activity. The LAB strains exhibited resistance to a wide variety of antimicrobials. It is most likely that this reflects intrinsic resistance (rather than genetic resistance which can be transferred) to the specified antimicrobials, due to lack of targets in the microbes for these antimicrobials. This property also makes them useful in combination with antibiotics, to prevent antibiotic-induced diarrhoea.

Probiotic bacteria prevent the growth of pathogenic species by competing for nutrition and attachment sites on the colonic epithelium, and through production of organic acids and bacteriocins[@ref26]. Several of the curd-derived LAB in this study inhibited growth of enteric pathogens. This is a useful property, especially to prevent the development of food-borne illness in tropical warm climates. Inhibition was noted specifically against *S*. Typhimurium and *V. cholerae* O139, but not against pathogenic *E. coli* or *S. flexneri*.

Adherence of lactobacilli to the intestinal epithelium is considered to be essential for the exertion of a beneficial (probiotic) effect in the large intestine[@ref27][@ref28]. Most of the LAB tested in this study displayed adherence to Caco-2 cells, in numbers similar to that previously reported by others[@ref28]. These LAB also inhibited pathogen adherence to Caco-2 cells. Such inhibition of pathogen adherence to eukaryotic cell lines has been reported for strains such as *L. johnsonii* La1, *Bifidobacterium* CA1 and F9, and *L. acidophilus* LB[@ref29][@ref30][@ref31]. In many cases, direct inhibitory activity has been linked to possible bacteriocin production by the probiotic strains and/or to their competitive adherence to epithelial cells, resulting in the inability of the pathogen to bind to its normal attachment site[@ref32]. The adhesion of *V. cholerae* O139 to Caco-2 cells was reduced to more than 50 per cent. Strains with higher adhesive ability might well occupy common adhesion sites and thus prevent the further adhesion of the pathogenic bacterium through a process of exclusion[@ref26]. On the other hand, even a weakly binding *Lactobacillus* strain on a Caco-2 cell could stimulate cellular mechanisms (immunomodulation), which may lead to increased colonization resistance or may interfere with pathogen adhesion to epithelium through mechanisms such as direct antagonism[@ref26]. Further studies are required to elucidate the mechanisms underlying probiotic adherence and inhibition of pathogen adherence.

Epithelial cells are major constituents of the intestinal mucosal barrier and participate in innate immune and inflammatory responses in the gut. Modulation of interleukin-8 secretion by epithelial cell line HT-29 is consistent with probiotic potential of the LAB tested. Sub-epithelial cells, including monocytes, also participate in inflammatory responses in the bowel, secreting inflammatory products such as Th1 type cytokines, chemokines and several active oxides. Expression of anti-inflammatory cytokines in the monocyte cell line THP-1 was upregulated by two of the LAB strains indicating the possibility of an anti-inflammatory effect. This needs to be confirmed by further study. Lactobacilli are known to have anti-inflammatory effects in animal models of colitis[@ref33].

It is likely that the daily ingestion of curd in certain cultures and communities confers health benefits beyond nutrient intake in curd. A recent study using an animal model and parallel human studies showed that though long term consumption of fermented milk products did not change faecal microbiota composition, it significantly changed the expression of microbial enzymes involved in many metabolic pathways, particularly those related to carbohydrate fermentation[@ref34].

In conclusion, the home-made curds that were evaluated possessed a spectrum of LAB that had the potential to exert probiotic effects in individuals consuming the curd. These microbes had properties that predicted their ability to survive passage in the upper gut and to modulate gut mucosal innate immune reactions and, therefore, it is likely they have the potential to significantly influence health status. Further studies should focus on the contribution of daily curd intake to health in India.
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